Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Boston Scientific launches new pacemaker family in Europe

Boston Scientific : 07 May, 2008  (New Product)
Boston Scientific has received CE Mark approval and has launched its Altrua family of pacemakers in Europe.
Altrua is Boston Scientific's most advanced pacemaker and delivers enhanced therapies while maintaining its small size and battery longevity.

The Altrua is the first Boston Scientific-branded pacemaker to treat bradycardia, a condition in which the heart beats too slowly - usually less than 60 beats per minute - depriving the body of sufficient oxygen.

'European approval of Boston Scientific's Altrua family of pacemakers is the latest example of the significant progress we have made rebuilding our CRM organization and reinvigorating our product pipeline,' said Fred Colen, executive vice president, Operations and Technology, CRM. 'Altrua's innovative technology - enabling physicians to adjust the therapy to meet the needs of their patients - demonstrates our renewed focus on treating bradycardia.'

The Altrua pacemaker provides physicians with a number of diagnostic and therapeutic capabilities that enable them to tailor the therapy to specific patient requirements:

- Multiple Atrial Ventricular (AV) Delay programming options: These options are designed to reduce unnecessary right ventricular (RV) pacing, without dropping ventricular beats, a key distinction from other competitive RV pacing algorithms. The Altrua 50 and 60 series also include an enhanced AV search hysteresis feature, now with an extendable AV delay out to 400 milliseconds, providing physicians with additional flexibility to tailor device programming for unique patient needs.

- Minute Ventilation (MV) Blended Sensor: This proprietary technology treats a condition called Chronotropic Incompetence, which is the inability of the heart to regulate its rate appropriately in response to physical activity and emotional stress. Boston Scientific's MV Blended sensor is the only sensor that has been shown to restore Chronotropic Competence.

- Ventricular Rate Regulation (VRR): This feature helps physicians manage patients with frequent atrial arrythmias.

- Automatic Capture: This capability is designed to offer automatic, safe and accurate ventricular pulse management. The device checks every heart beat to see if the lower chambers of the heart contract in response to the delivered pulse. If no contraction is detected, a backup pace with more energy is delivered.

The Altrua family of pacemakers is currently awaiting approval by the US Food and Drug Administration and is not available for sale in the USA.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo